- PR Newswire•25 days ago
KALAMAZOO, Mich., March 1, 2017 /PRNewswire/ -- Medizone International, Inc. (MZEI), the developer of AsepticSure®, the only EPA cleared hospital room disinfection technology that combines ozone and hydrogen peroxide to achieve unprecedented kill rates of bacteria and viral pathogens, announced today that the Company has entered into a definitive agreement with EMA Partners retaining them as the Company's advisor for financing and investment banking matters. "We are very pleased to announce that Medizone International has reached an agreement to have EMA Partners serve as our advisor and investment bank.
- PR Newswire•27 days ago
Effective March 1, 2017, Edwin Marshall, current Chairman and CEO, will step down from leadership of the Company and will become an advisor to the Chairman through this period of transition. "It has been an honor to lead Medizone International for the last 20 years," commented Ed.
- PR Newswire•3 months ago
SAN FRANCISCO, Dec. 12, 2016 /PRNewswire/ -- Medizone International, Inc. (The Company) (OTCQB:MZEI) Following its recently announced EPA approval to enter the US market with its WHO Award winning and ...
MZEI : Summary for MEDIZONE INTL INC COM USD0.001 - Yahoo Finance
Medizone International, Inc. (MZEI)
OTC BB - OTC BB Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.09 - 0.11|
|52 Week Range||0.04 - 0.17|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-22.00|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|